Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Taal

Showing results (21-30 of 228) with videos related to

Pageof 23
Sort By:
Current Opinion in Nephrology and Hypertension|October 23, 2008
How to measure proteinuria?Natasha J McIntyre, Maarten W Taal
Nephron. Clinical Practice|May 11, 2011
Renal Association Clinical Practice Guideline on detection, monitoring and management of patients with CKDMark S MacGregor, Maarten W Taal
Current Opinion in Nephrology and Hypertension|October 3, 2020
Nutritional status assessment: a neglected biomarker in persons with end-stage kidney diseaseDaniela Viramontes-Hörner, Maarten W Taal
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 28, 2024
Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT TrialsMaarten W Taal, Nicholas M Selby
Kidney International|May 3, 2000
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonistsM W Taal, B M Brenner
Journal of Human Hypertension|March 17, 1999
ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat modelsM W Taal, B M Brenner
Kidney International|March 7, 2008
Renal risk scores: progress and prospectsM W Taal, B M Brenner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 2025
Trends in nephrology: decades later, the importance of glomerular hyperfiltration in daily kidney careValerie A Luyckx, Maarten W Taal
Lancet (London, England)|November 7, 2022
Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?Nicholas M Selby, Maarten W Taal
Current Opinion in Nephrology and Hypertension|July 10, 2002
Combination ACEI and ARB therapy: additional benefit in renoprotection?Maarten W Taal, Barry M Brenner
Pageof 23

Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Current Opinion in Nephrology and Hypertension|October 23, 2008
How to measure proteinuria?Natasha J McIntyre, Maarten W Taal
Nephron. Clinical Practice|May 11, 2011
Renal Association Clinical Practice Guideline on detection, monitoring and management of patients with CKDMark S MacGregor, Maarten W Taal
Current Opinion in Nephrology and Hypertension|October 3, 2020
Nutritional status assessment: a neglected biomarker in persons with end-stage kidney diseaseDaniela Viramontes-Hörner, Maarten W Taal
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 28, 2024
Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT TrialsMaarten W Taal, Nicholas M Selby
Kidney International|May 3, 2000
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonistsM W Taal, B M Brenner
Journal of Human Hypertension|March 17, 1999
ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat modelsM W Taal, B M Brenner
Kidney International|March 7, 2008
Renal risk scores: progress and prospectsM W Taal, B M Brenner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 2025
Trends in nephrology: decades later, the importance of glomerular hyperfiltration in daily kidney careValerie A Luyckx, Maarten W Taal
Lancet (London, England)|November 7, 2022
Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?Nicholas M Selby, Maarten W Taal
Current Opinion in Nephrology and Hypertension|July 10, 2002
Combination ACEI and ARB therapy: additional benefit in renoprotection?Maarten W Taal, Barry M Brenner
Pageof 23